Skip to search formSkip to main contentSkip to account menu

olanzapine

Known as: olanzapine [Chemical/Ingredient], 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine, Zolafren 
A synthetic derivative of thienobenzodiazepine with antipsychotic, antinausea, and antiemetic activities. As a selective monoaminergic antagonist… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
OBJECTIVE This study assessed the efficacy of olanzapine in delaying or preventing conversion to psychosis and reducing symptoms… 
Highly Cited
2005
Highly Cited
2005
BACKGROUND The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents… 
Highly Cited
2004
Highly Cited
2004
ObjectiveTo compare the safety and estimate the response profile of olanzapine, a second-generation antipsychotic, to haloperidol… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND Despite the longer duration of the depressive phase in bipolar disorder and the frequent clinical use of… 
Review
1999
Review
1999
Cognitive function is markedly impaired in most patients with schizophrenia. Antecedents of this impairment are evident in… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE Dopamine D2 receptor occupancy measurements provide a valid predictor of antipsychotic response, extrapyramidal side… 
Review
1999
Review
1999
Multicentre trials in patients with schizophrenia confirm that olanzapine is a novel antipsychotic agent with broad efficacy… 
Highly Cited
1996
Highly Cited
1996